Insider: Butler John P. CEO and President - Akebia Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,557,921 | 0 | 2,557,921 |
| Value | $7,008,703.54 | $0.00 | $7,008,703.54 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/03/2025 | DDS | 46,409 | Direct | COM | $1.83 | $84,928.47 | 2,557,921 |
| 02/03/2025 | DDS | 46,268 | Direct | COM | $2.10 | $97,162.80 | 2,702,312 |
| 02/03/2025 | DDS | 97,982 | Direct | COM | $2.10 | $205,762.20 | 2,604,330 |
| 02/29/2024 | DDS | 46,570 | Direct | COM | $1.58 | $73,580.60 | 2,044,580 |
| 02/27/2024 | DDS | 37,733 | Direct | COM | $1.52 | $57,354.16 | 2,091,150 |
| 02/01/2024 | DDS | 46,489 | Direct | COM | $1.68 | $78,101.52 | 2,128,883 |
| 03/01/2023 | DDS | 6,370 | Direct | COM | $0.88 | $5,589.68 | 1,568,872 |
| 03/01/2023 | DDS | 38,259 | Direct | COM | $0.88 | $33,572.27 | 1,622,481 |
| 03/01/2023 | DDS | 47,239 | Direct | COM | $0.88 | $41,452.22 | 1,575,242 |
| 02/27/2023 | DDS | 38,632 | Direct | COM | $0.81 | $31,415.54 | 1,660,740 |
| 03/01/2022 | DDS | 24,811 | Direct | COM | $2.17 | $53,857.24 | 1,432,409 |
| 03/01/2022 | DDS | 25,031 | Direct | COM | $2.17 | $54,334.79 | 1,407,378 |
| 03/01/2022 | DDS | 4,131 | Direct | COM | $2.17 | $8,967.16 | 1,403,247 |
| 02/28/2022 | DDS | 25,053 | Direct | COM | $2.15 | $53,984.20 | 1,164,095 |
| 04/01/2021 | DDS | 4,109 | Direct | COM | $3.40 | $13,970.60 | 1,152,153 |
| 03/01/2021 | DDS | 25,316 | Direct | COM | $3.40 | $85,975.67 | 1,141,416 |
| 03/01/2021 | DDS | 24,674 | Direct | COM | $3.40 | $83,795.37 | 1,116,742 |
| 11/20/2019 | AAP | 50,000 | Direct | COM | $3.44 | $172,000.00 | 887,732 |
| 12/29/2014 | AAP | 1,000 | Direct | COM | $11.57 | $11,567.20 | 48,350 |
| 12/22/2014 | AAP | 1,000 | Direct | COM | $11.92 | $11,916.00 | 47,350 |
| 12/15/2014 | AAP | 1,000 | Direct | COM | $11.34 | $11,336.40 | 46,350 |
| 11/12/2014 | AAP | 1,000 | Direct | COM | $10.31 | $10,305.00 | 45,350 |
| 03/25/2014 | AAP | 13,850 | Direct | COM | $17.00 | $235,450.00 | 13,850 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research